AI-generated summary
The authors report a meta-analysis of 14 randomized controlled trials including 869 patients with head and neck cancer, examining photobiomodulation therapy for chemoradiotherapy-induced oral mucositis. They found lower incidence of mucositis, lower rates of severe mucositis, and reduced mucositis-related pain in the photobiomodulation groups compared with controls. The authors note the results are heterogeneous in some outcomes and call for further research on optimal parameters.
- Participants
- 869
- Studies included
- 14
- Who or what was studied
- Patients with head and neck cancer receiving chemoradiotherapy
- Limits stated in the abstract
- The abstract notes substantial heterogeneity (I2 up to 89%) in some outcomes and that optimal treatment parameters remain to be determined.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 25 mW
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis, Meta-analysis, Systematic review, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.